Imagawa K, Kawasaki M, Toda I, Hayashi M, Asai A, Nomura T
Gan To Kagaku Ryoho. 1982 Sep;9(9):1543-8.
Various nitrosoureas are widely used effectively for chemotherapy of brain tumors, clinically and experimentally. Fourteen cases of malignant brain tumor received intravenous injection of 100-150 mg/body of ACNU, and the concentration of ACNU in blood and cerebrospinal fluid (CSF) was measured. The conclusion drawn from this study on penetration of ACNU is summarized as follows: 1. ACNU concentration in CSF and its ratio to that of serum (CSF/serum %) showed the various values of 0-0.076 micrograms/ml (0-63%), 30 min. after administration; 2. Concentration of ACNU in spinal CSF differed from that in ventricular CSF and CSF/serum ratio was 19.9% in spinal CSF and 42% in ventricular CSF, respectively; 3. Statistically no correlation between ACNU CSF/serum ratio and the postoperative time was found. Transition of ACNU into cerebrospinal fluid during radiation therapy was noted with high value of CSF/serum ratio.
临床上和实验中,各种亚硝基脲类药物被广泛有效地用于脑肿瘤化疗。14例恶性脑肿瘤患者静脉注射了每体100 - 150毫克的嘧啶亚硝脲(ACNU),并测定了血液和脑脊液(CSF)中ACNU的浓度。关于ACNU渗透的这项研究得出的结论总结如下:1. 给药30分钟后,脑脊液中ACNU浓度及其与血清浓度之比(脑脊液/血清%)显示出0 - 0.076微克/毫升(0 - 63%)的不同数值;2. 脊髓脑脊液中ACNU浓度与脑室脑脊液中的不同,脊髓脑脊液中脑脊液/血清比分别为19.9%,脑室脑脊液中为42%;3. 统计学上未发现ACNU脑脊液/血清比与术后时间之间存在相关性。在放射治疗期间,观察到ACNU向脑脊液的转变,脑脊液/血清比具有高值。